HOME >> BIOLOGY >> NEWS
Aspirin use safe and effective in patients with abnormal red cell counts (or with polycythemia)

(San Diego, Calif., December 7, 2003) The use of low-dose aspirin significantly reduces the risk of thrombosis in patients with polycythemia vera, an abnormal increase in blood cells resulting from excess production by the bone marrow, according to a study presented today during the 45th Annual Meeting of the American Society of Hematology. Thrombosis is the formation or presence of a blood clot within a vessel that may cause a stroke or heart attack.

"These results indicate a high benefit/risk ratio of aspirin in a polycythemic population, suggesting that aspirin should be used in all patients with polycythemia vera having no contraindication to this treatment," said Raffaele Landolfi, M.D., of the Istituto di Medicina Interna e Geriatria, Universit Cattolica, Rome, Italy, lead author of the study.

Aspirin treatment (100 mg per day) significantly reduced the risk of thrombosis in polycythemic patients who were undergoing standard cytoreductive treatments (therapies aimed at reducing the number of blood cells). Treatment with aspirin lowered the risk of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, pulmonary embolism, and venous thrombosis. The risk of minor thrombotic events was also significantly decreased.

Researchers reported no excess of major bleeding in patients on aspirin treatment. Major, total, and gastrointestinal bleedings were not significantly increased. Only the risk of nosebleeds, or epistaxix, was significantly increased.

Polycythemia vera is an acquired disorder of the bone marrow that causes the overproduction of all three blood cell lines white and red blood cells and platelets. It is a relatively rare disease that occurs more frequently in men than women, usually within the age range of 40 to 80, although it may occur in younger subjects. Polycythemia vera develops slowly, and most patients do not experience any problems related to the disease
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
7-Dec-2003


Page: 1 2

Related biology news :

1. Aspirin may not be strong enough to prevent clots in some heart patients
2. Aspirin could reduce the risk of deadly infections
3. Aspirin prevents polyps in colon cancer patients
4. Aspirin inhibits ovarian cancer growth, lab study finds
5. Aspirin targets key cell that triggers organ rejection and other immune responses, report University of Pittsburgh researchers in journal article
6. Aspirin use may increase pancreatic cancer risk
7. How Super Are The "Super Aspirins"? -- New COX-2 Inhibitors May Elevate Cardiovascular Risk
8. Aspirin Decreases Genetic Mutations Associated With Inherited Colon Cancer
9. Study Shows Aspirin Blocks "Plant Pain"
10. Aspirins Preventive Action In Heart Attacks Tied To Genetics
11. International study findings link acne-like rash to effectiveness of new targeted cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 19, 2018 , ... Superior Controls, Inc. ... with 150 employees on both the east and west coasts, today announced the ... 2018 International Society of Pharmaceutical Engineering (ISPE) Product Show and Career Fair at ...
(Date:9/22/2018)... ... 2018 , ... We are excited to announce the release ... recently launched NovoCyte QuanteonTM flow cytometers and NovoSampler® Q autosampler ... , In addition to the functionalities supporting the expanded flow cytometer products ...
(Date:9/22/2018)... (PRWEB) , ... September 21, 2018 , ... ... worry-free outcome. However, the implant manufacturer’s warranty does not always protect them against ... their breast augmentation with the IDEAL IMPLANT Premium Protection Plan for ...
Breaking Biology News(10 mins):
(Date:9/22/2018)... ... September 21, 2018 , ... ... tissue function, development, and pathogenesis requires tools that can rapidly and consistently ... Multiplexed Ion Beam Imaging by Time-Of-Flight (MIBI-TOF) detects elements from hydrogen to ...
(Date:9/12/2018)... ... 10, 2018 , ... Franz Inc. , an early innovator in Artificial ... Knowledge Graphs, and Semantic Web Company , developers of the PoolParty Semantic ... develop the Noam Chomsky Knowledge Graph. This project is the first aimed ...
(Date:9/7/2018)... SANTA CLARA, Calif. (PRWEB) , ... September 05, 2018 , ... ... sponsored by Park Systems will be held on Sept. 19, 2018. With a panel ... trends on SPM, this exciting event will reveal industry insights from experts in the ...
(Date:9/7/2018)... ... 06, 2018 , ... Akadeum Life Sciences today announced it has appointed George ... and leader of numerous biotech companies. , He most recently served as president ... Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was a ...
Breaking Biology Technology:
Cached News: